Vulvar dystrophies: an evaluation.
Of 86 patients diagnosed as having vulvar dystrophy in a 10-year period 56 (65.1%) had hyperplastic dystrophy, 23 (26.7%) had lichen sclerosus and 7 (26.7%) had mixed vulvar dystrophy. The diagnoses were made by colposcopic or toluidine blue directed biopsies. Fluorinated corticosteroids were given to patients with hyperplastic dystrophy with a response rate of 90.1%. Patients with lichen sclerosus received topical testosterone propionate and the response rate was 87.7%. Topical fluorinated corticosteroids followed by testosterone propionate was given to patients with mixed dystrophy and 85.8% of the patients responded. Surgical therapy was reserved for patients with failed medical treatment.
Ayhan
A
A
Department of Obstetrics and Gynaecology, University of Hacettepe, Faculty of Medicine, Ankara, Turkey.
Yüce
K
K
Urman
B
B
Ayhan
A
A
Gököz
A
A
D000328:Adult; D000368:Aged; D005260:Female; D005443:Flumethasone / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D013739:Testosterone / Q000627:therapeutic use; D014845:Vulvar Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery
D013739:Testosterone; D005443:Flumethasone